In its earnings report, to be released Aug. 4, analysts estimate the pharmacy benefits manager will post earnings of $2.07 per share, a 21.59 percent year-over-year decrease.
However, the Zacks Consensus Estimate projects revenue of $70.08 billion, a 7.25 percent increase year over year, the article said.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
